Antiviral treatment of chronic hepatitis B virus infection: Improvement in liver disease with interferon and adenine arabinoside
- 1 May 1981
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 1 (3), 228-232
- https://doi.org/10.1002/hep.1840010306
Abstract
Twelve of 32 patients lost HBeAg and DNA polymerase from their serum after completing antiviral therapy with interferon and/or adenine arabinoside. Three lost serum HBsAg as well. Loss of corresponding viral markers from hepatic tissue was also seen. There was improvement in symptoms, hepatic tests, and histologic findings in the 12 patients whose viral markers disappeared when compared to the 20 whose viral markers persisted despite treatment. These findings provide support for the use of antiviral agents in hepatitis B positive chronic liver disease.This publication has 8 references indexed in Scilit:
- SERUM LEVELS OF HEPATITIS B SURFACE AND CORE ANTIGENS DURING IMMUNOSUPPRESSIVE TREATMENT OF HBsAg-POSITIVE CHRONIC ACTIVE HEPATITISThe Lancet, 1980
- Long-term Follow-up of e-Antigen (HBeAg)-positive Acute Viral HepatitisScandinavian Journal of Gastroenterology, 1979
- StatisticsWiley Series in Probability and Statistics, 1977
- Correlation of e Antigen, DNA Polymerase Activity, and Dane Particles in Chronic Benign and Chronic Active Type B Hepatitis InfectionsThe Journal of Infectious Diseases, 1977
- Immunological aspects of hepatitis B virus infectionThe American Journal of the Medical Sciences, 1975
- INADEQUATE ANTIBODY RESPONSE TO HBAg OR SUPPRESSOR T-CELL DEFECT IN DEVELOPMENT OF ACTIVE CHRONIC HEPATITISThe Lancet, 1974
- NATURAL HISTORY OF HEPATITIS-ASSOCIATED ANTIGEN-POSITIVE CHRONIC LIVER DISEASEThe Lancet, 1972
- RELATIONSHIP OF HEPATITIS-ASSOCIATED ANTIGEN (H.A.A.) TO ACUTE AND CHRONIC LIVER INJURYThe Lancet, 1971